| Literature DB >> 23717492 |
Brian E Eisinger1, Changjiu Zhao, Terri M Driessen, Michael C Saul, Stephen C Gammie.
Abstract
Coordinated gene expression changes across the CNS are required to produce the mammalian maternal phenotype. Lateral septum (LS) is a brain region critically involved with aspects of maternal care, and we recently examined gene expression of whole septum (LS and medial septum) in selectively bred maternal mice. Here, we expand on the prior study by 1) conducting microarray analysis solely on LS in virgin and postpartum mice, 2) using outbred mice, and 3) evaluating the role of sensory input on gene expression changes. Large scale changes in genes related to neuronal signaling were identified, including four GABAA receptor subunits. Subunits α4 and δ were downregulated in maternal LS, likely reflecting a reduction in the extrasynaptic, neurosteroid-sensitive α4/δ containing receptor subtype. Conversely, subunits ε and θ were increased in maternal LS. Fifteen K+ channel related genes showed altered expression, as did dopamine receptors Drd1a and Drd2 (both downregulated), hypocretin receptor 1 (Hcrtr1), kappa opioid receptor 1 (Oprk1), and transient receptor potential channel 4 (Trpc4). Expression of a large number of genes linked to developmental processes or cell differentiation were also altered in postpartum LS, including chemokine (C-X-C) motif ligand 12 (Cxcl12), fatty acid binding protein 7 (Fabp7), plasma membrane proteolipid (Pllp), and suppressor of cytokine signaling 2 (Socs2). Additional genes that are linked to anxiety, such as glutathione reductase (Gsr), exhibited altered expression. Pathway analysis also identified changes in genes related to cyclic nucleotide metabolism, chromatin structure, and the Ras gene family. The sensory presence of pups was found to contribute to the altered expression of a subset of genes across all categories. This study suggests that both large changes in neuronal signaling and the possible terminal differentiation of neuronal and/or glial cells play important roles in producing the maternal state.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23717492 PMCID: PMC3661729 DOI: 10.1371/journal.pone.0063824
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic representation of the brain regions dissected for microarray and qPCR experiments.
Dissections are outlined in red. Distance from Bregma in the rostrocaudal plane is indicated. Reprinted and modified from The Allen Mouse Brain Atlas (reference atlas version 1, 2008). Abbreviations: LSc, caudal part of the lateral septal nucleus; LSr, rostral part of the lateral septal nucleus; MS; medial septal nucleus; VL, lateral ventricle; aco, anterior commissure, olfactory limb.
List of the 100 most significant gene expression differences between LS of lactating maternal mice and age-matched virgins.
| Accession No. | Gene Symbol | Gene Title | Fold Change | |
|
| ||||
| NM_001079883 | Bcl11b | B-cell leukemia/lymphoma 11B | 0.79 | |
| NM_007537 | Bcl2l2 | BCL2-like 2 | 1.10 | |
| NM_009668 | Bin1 | bridging integrator 1 | 1.11 | |
| NM_011636 | Plscr1 | phospholipid scramblase 1 | 1.13 | |
|
| ||||
| NM_183187 | Fam107a | family with sequence similarity 107, member A | 1.17 | |
| NM_183183 | Gprin3 | GPRIN family member 3 | 0.79 | |
| NM_008258 | Hn1 | hematological and neurological expressed sequence 1 | 0.90 | |
| NM_001161535 | Islr2 | immunoglobulin superfamily containing leucine-rich repeat 2 | 0.85 | |
| NM_010660 | Krt10 | keratin 10 | 0.91 | |
| NM_178714 | Lrfn5 | leucine rich repeat and fibronectin type III domain containing 5 | 1.10 | |
| NM_177725 | Lrrc8a | leucine rich repeat containing 8A | 1.10 | |
| NM_028190 | Luc7l | Luc7 homolog (S. cerevisiae)-like | 1.08 | |
| NM_146061 | Prr5 | proline rich 5 (renal) | 1.13 | |
| NM_011386 | Skil | SKI-like | 0.83 | |
| NM_011418 | Smarcb1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.92 | |
| NM_133786 | Smc4 | structural maintenance of chromosomes 4 | 0.84 | |
| NM_001033272 | Spata13 | spermatogenesis associated 13 | 0.79 | |
|
| ||||
| NM_139306 | Acer2 | alkaline ceramidase 2 | 1.32 | |
| NM_177872 | Adamts3 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 | 0.74 | |
| NM_009625 | Adcyap1 | adenylate cyclase activating polypeptide 1 | 1.13 | |
| NM_018737 | Ctps2 | cytidine 5′-triphosphate synthase 2 | 1.10 | |
| NM_016699 | Exosc10 | exosome component 10 | 0.96 | |
| NM_021896 | Gucy1a3 | guanylate cyclase 1, soluble, alpha 3 | 0.81 | |
| NM_008509 | Lpl | lipoprotein lipase | 0.65 | |
| NM_172948 | Mgat5b | mannoside acetylglucosaminyltransferase 5, isoenzyme B | 0.91 | |
| NM_019840 | Pde4b | phosphodiesterase 4B, cAMP specific | 0.91 | |
| NM_172267 | Phyhd1 | phytanoyl-CoA dioxygenase domain containing 1 | 1.20 | |
| NM_029614 | Prss23 | protease, serine, 23 | 1.17 | |
| NM_027997 | Serpina9 | serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 | 0.52 | |
|
| ||||
| NM_177407 | Camk2a | calcium/calmodulin-dependent protein kinase II alpha | 0.95 | |
| NM_146125 | Itpka | inositol 1,4,5-trisphosphate 3-kinase A | 0.86 | |
| NM_175171 | Mast4 | microtubule associated serine/threonine kinase family member 4 | 1.13 | |
| NM_008587 | Mertk | c-mer proto-oncogene tyrosine kinase | 1.24 | |
| NM_016891 | Ppp2r1a | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform | 0.95 | |
|
| ||||
| NM_172835 | Peli3 | pellino 3 | 1.09 | |
| NM_144873 | Uhrf2 | ubiquitin-like, containing PHD and RING finger domains 2 | 1.14 | |
| NM_001033173 | Usp31 | ubiquitin specific peptidase 31 | 1.14 | |
| NM_025830 | Wwp2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.94 | |
|
| ||||
| NM_010155 | Erf | Ets2 repressor factor | 0.88 | |
| NM_175660 | Hist1h2ab | histone cluster 1, H2ab | 0.68 | |
| NM_013550 | Hist1h3a | histone cluster 1, H3a | 0.78 | |
| NM_178203 | Hist1h3b | histone cluster 1, H3b | 0.77 | |
| NM_178204 | Hist1h3d | histone cluster 1, H3d | 0.78 | |
| NM_178204 | Hist1h3e | histone cluster 1, H3d | 0.78 | |
| NM_145073 | Hist1h3g | histone cluster 1, H3g | 0.77 | |
| NM_178206 | Hist1h3h | histone cluster 1, H3h | 0.77 | |
| NM_178207 | Hist1h3i | histone cluster 1, H3i | 0.78 | |
| NM_175662 | Hist2h2ac | histone cluster 2, H2ac | 0.88 | |
| NM_001013813 | Maml2 | mastermind like 2 (Drosophila) | 0.87 | |
| NM_001033713 | Mef2a | myocyte enhancer factor 2A | 0.91 | |
| NM_001136072 | Meis2 | Meis homeobox 2 | 0.88 | |
| NM_172788 | Sh3rf3 | SH3 domain containing ring finger 3 | 1.11 | |
| NM_172913 | Tox3 | TOX high mobility group box family member 3 | 0.86 | |
|
| ||||
| NM_133237 | Apcdd1 | adenomatosis polyposis coli down-regulated 1 | 0.88 | |
| NM_207655 | Egfr | epidermal growth factor receptor | 0.85 | |
| NM_008072 | Gabrd | gamma-aminobutyric acid (GABA) A receptor, subunit delta | 0.75 | |
| NM_175668 | Gpr4 | G protein-coupled receptor 4 | 1.19 | |
| NM_146072 | Grik1 | glutamate receptor, ionotropic, kainate 1 | 1.21 | |
| NM_181850 | Grm3 | glutamate receptor, metabotropic 3 | 0.87 | |
| NM_174998 | Hpcal4 | hippocalcin-like 4 | 0.89 | |
| NM_013568 | Kcna6 | potassium voltage-gated channel, shaker-related, subfamily, member 6 | 1.14 | |
| NM_010597 | Kcnab1 | potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 0.86 | |
| NM_008427 | Kcnj4 | potassium inwardly-rectifying channel, subfamily J, member 4 | 0.72 | |
| NM_001081027 | Kcnt2 | potassium channel, subfamily T, member 2 | 1.15 | |
| NM_001081298 | Lphn2 | latrophilin 2 | 0.86 | |
| NM_024200 | Mfn1 | mitofusin 1 | 1.15 | |
| NM_152229 | Nr2e1 | nuclear receptor subfamily 2, group E, member 1 | 0.85 | |
| NM_178751 | Orai2 | ORAI calcium release-activated calcium modulator 2 | 0.86 | |
| NM_177411 | Rab5b | RAB5B, member RAS oncogene family | 0.91 | |
| NM_011243 | Rarb | retinoic acid receptor, beta | 0.66 | |
| NM_009107 | Rxrg | retinoid X receptor gamma | 0.71 | |
| NM_011313 | S100a6 | S100 calcium binding protein A6 (calcyclin) | 0.81 | |
| NM_030889 | Sorcs2 | sortilin-related VPS10 domain containing receptor 2 | 0.91 | |
| NM_016908 | Syt5 | synaptotagmin V | 0.94 | |
| NM_021344 | Tesc | tescalcin | 0.82 | |
| NM_011648 | Tshr | thyroid stimulating hormone receptor | 0.82 | |
| NM_031877 | Wasf1 | WASP family 1 | 0.91 | |
|
| ||||
| NM_178627 | Poldip3 | polymerase (DNA-directed), delta interacting protein 3 | 0.94 | |
| NM_024212 | Rpl4 | ribosomal protein L4 | 0.92 | |
| NM_007475 | Rplp0 | ribosomal protein, large, P0 | 0.90 | |
| NM_177214 | Snrnp200 | small nuclear ribonucleoprotein 200 (U5) | 0.92 | |
|
| ||||
| NM_017391 | Slc5a3 | solute carrier family 5 (inositol transporters), member 3 | 1.16 | |
| NM_194355 | Spire1 | spire homolog 1 (Drosophila) | 1.07 | |
|
| ||||
| NM_133729 | 2610018G03Rik | RIKEN cDNA 2610018G03 gene | 0.80 | |
| ENSMUST00000055842 | Armcx4 | armadillo repeat containing, X-linked 4 | 1.15 | |
| NM_027560 | Arrdc2 | arrestin domain containing 2 | 1.13 | |
| NM_028386 | Asphd2 | aspartate beta-hydroxylase domain containing 2 | 0.87 | |
| BC096543 | B930095G15Rik | RIKEN cDNA B930095G15 gene | 1.14 | |
| NM_027909 | C2cd2l | C2 calcium-dependent domain containing 2-like | 0.90 | |
| NM_030179 | Clip4 | CAP-GLY domain containing linker protein family, member 4 | 0.88 | |
| NM_146067 | Cpped1 | calcineurin-like phosphoesterase domain containing 1 | 0.88 | |
| NM_198866 | Dbpht2 | DNA binding protein with his-thr domain | 0.85 | |
| NM_001134457 | Fam55c | family with sequence similarity 55, member C | 1.10 | |
| NM_178673 | Fstl5 | follistatin-like 5 | 1.16 | |
| NM_207222 | Lmo3 | LIM domain only 3 | 0.81 | |
| NM_001164805 | Thsd7a | thrombospondin, type I, domain containing 7A | 0.81 | |
| NM_198627 | Vstm2l | V-set and transmembrane domain containing 2-like | 0.90 | |
| NM_001081382 | Zfp777 | zinc finger protein 777 | 0.92 | |
| NM_013859 |
| zinc finger, HIT domain containing 2, pseudogene | 0.90 | |
| NM_145456 | Zswim6 | zinc finger, SWIM domain containing 6 | 0.84 | |
All expression changes in Table 1 have FDR-adjusted p-values less than 0.11. Expression is given as fold change in lactating maternal LS relative to virgin; numbers greater than 1.0 indicate increases in maternal mice.
Figure 2Quantitative real-time PCR analysis of GABAA receptor subunit expression in lateral septum.
Relative expression distribution (Y-axis) represented as a ratio of lactating maternal versus virgin (top panel, n = 8/group) and lactating maternal versus pups removed (bottom panel, n = 8/group), was normalized against two reference genes, Ppia and Ywhaz, and shown by box-and-whisker plots as medians (white lines), interquartile ranges (boxes), and ranges (whiskers). Ratios over one indicate genes that are more highly expressed in lactating maternal LS than in virgin or pups removed LS. *p<0.05; **p<0.01; ***p<0.001.
Figure 3Quantitative real-time PCR analysis of gene expression in lateral septum.
Relative expression distribution (Y-axis) represented as a ratio of lactating maternal versus virgin (top panel, n = 8/group) and lactating maternal versus pups removed (bottom panel, n = 8/group), was normalized against two reference genes, Ppia and Ywhaz, and shown by box-and-whisker plots as medians (white lines), interquartile ranges (boxes), and ranges (whiskers). Ratios over one indicate genes that are more highly expressed in lactating maternal LS than in virgin or pups removed LS. *p<0.05; **p<0.01; ***p<0.001.
Figure 4Gene clusters found to be enriched in the LS of lactating maternal mice relative to virgin mice as interaction networks.
Gene lists for each cluster are presented to the left of their respective network visualization. Gene symbols in bold text are upregulated in lactating maternal LS relative to virgin, and are represented in the network images as dark nodes with white text. Non-bold gene symbols and grey nodes with dark text correspond to genes that are downregulated. The nature of the interaction data linking any two nodes is encoded by color. Distance between nodes is proportional to the strength of evidence for their interactions.
Figure 5Cluster of genes enriched in maternal LS related to developmental processes and cell differentiation.
Gene lists for the cluster is presented to the left of the network visualization. Gene symbols in bold text are upregulated in lactating maternal LS relative to virgin, and are represented in the network images as dark nodes with white text. Non-bold gene symbols and grey nodes with dark text correspond to genes that are downregulated. The nature of the interaction data linking any two nodes is encoded by color. Distance between nodes is proportional to the strength of evidence for their interactions.
List of 68 genes that displayed significant expression changes in the LS of lactating maternal mice compared to both virgin and pups removed groups.
| Accession No. | Gene Symbol | Gene Title | Fold Change (vs.pups removed) | Fold Change(vs. virgin) | |
|
| |||||
| NM_170597 | Creg2 | cellular repressor of E1A-stimulated genes 2 | 0.90 | 0.92 | |
| NM_001166273 | Cspg5 | chondroitin sulfate proteoglycan 5 | 0.90 | 0.92 | |
| NM_183187 | Fam107a | family with sequence similarity 107, member A | 1.26 | 1.17 | |
| NM_011812 | Fbln5 | fibulin 5 | 1.24 | 1.19 | |
| NM_010218 | Fjx1 | four jointed box 1 (Drosophila) | 0.84 | 0.87 | |
| NM_008538 | Marcks | myristoylated alanine rich protein kinase C substrate | 0.90 | 0.88 | |
| NR_033728 | Nit1 | nitrilase 1 | 1.06 | 1.08 | |
| NM_011386 | Skil | SKI-like | 0.87 | 0.83 | |
|
| |||||
| NM_001081204 | B3galtl | beta 1,3-galactosyltransferase-like | 0.91 | 0.92 | |
| NM_028979 | Cyp2j9 | cytochrome P450, family 2, subfamily j, polypeptide 9 | 1.18 | 1.14 | |
| NM_172948 | Mgat5b | mannoside acetylglucosaminyltransferase 5, isoenzyme B | 0.88 | 0.91 | |
| NM_172267 | Phyhd1 | phytanoyl-CoA dioxygenase domain containing 1 | 1.27 | 1.20 | |
| NM_029614 | Prss23 | protease, serine, 23 | 1.17 | 1.17 | |
| NM_001101430 | Psmg4 | proteasome (prosome, macropain) assembly chaperone 4 | 0.90 | 0.91 | |
| NM_133670 | Sult1a1 | sulfotransferase family 1A, phenol-preferring, member 1 | 1.34 | 1.30 | |
|
| |||||
| NM_009652 | Akt1 | thymoma viral proto-oncogene 1 | 0.93 | 0.92 | |
| NM_008587 | Mertk | c-mer proto-oncogene tyrosine kinase | 1.26 | 1.24 | |
| NM_016891 | Ppp2r1a | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform | 0.95 | 0.95 | |
|
| |||||
| NM_173784 | Ubtd2 | ubiquitin domain containing 2 | 0.87 | 0.90 | |
| NM_144873 | Uhrf2 | ubiquitin-like, containing PHD and RING finger domains 2 | 1.13 | 1.14 | |
|
| |||||
| BC024814 | BC024814 | cDNA sequence BC024814 | 0.87 | 0.90 | |
| NM_023876 | Elp4 | elongation protein 4 homolog (S. cerevisiae) | 0.91 | 0.93 | |
| NM_133658 | Ercc3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 | 0.93 | 0.93 | |
| NM_178213 | Hist2h2ab | histone cluster 2, H2ab | 0.89 | 0.87 | |
| NM_175662 | Hist2h2ac | histone cluster 2, H2ac | 0.90 | 0.88 | |
| NM_001033713 | Mef2a | myocyte enhancer factor 2A | 0.93 | 0.91 | |
| NR_030470 | Mir669a-2 | microRNA 669a-2 | 1.24 | 1.20 | |
| NM_181650 | Prdm4 | PR domain containing 4 | 0.93 | 0.95 | |
| NM_001166410 | Rbm3 | RNA binding motif protein 3 | 0.70 | 0.76 | |
| NM_001024918 | Rfx4 | regulatory factor X, 4 (influences HLA class II expression) | 0.86 | 0.89 | |
| NM_029949 | Snapc3 | small nuclear RNA activating complex, polypeptide 3 | 1.06 | 1.07 | |
| NM_001168578 | Tceal8 | transcription elongation factor A (SII)-like 8 | 0.88 | 0.86 | |
| NM_172913 | Tox3 | TOX high mobility group box family member 3 | 0.87 | 0.86 | |
| NM_001164578 | Tsr2 | TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) | 0.94 | 0.91 | |
| NM_144546 | Zfp119a | zinc finger protein 119a | 0.87 | 0.89 | |
|
| |||||
| NM_133237 | Apcdd1 | Adenomatosis polyposis coli down-regulated 1 | 0.83 | 0.88 | |
| NM_008533 | Cd180 | CD180 antigen | 0.86 | 0.84 | |
| NM_009895 | Cish | cytokine inducible SH2-containing protein | 1.20 | 1.20 | |
| NM_010108 | Efna3 | ephrin A3 | 0.91 | 0.89 | |
| NM_207655 | Egfr | epidermal growth factor receptor | 0.89 | 0.85 | |
| NM_053072 | Fgd6 | FYVE, RhoGEF and PH domain containing 6 | 1.09 | 1.08 | |
| NM_175668 | Gpr4 | G protein-coupled receptor 4 | 1.18 | 1.19 | |
| NM_001081298 | Lphn2 | latrophilin 2 | 0.89 | 0.86 | |
| NM_001083897 | Mpzl1 | myelin protein zero-like 1 | 0.91 | 0.91 | |
| NM_019515 | Nmu | neuromedin U | 1.35 | 1.42 | |
| NM_152229 | Nr2e1 | nuclear receptor subfamily 2, group E, member 1 | 0.87 | 0.85 | |
| NM_178751 | Orai2 | ORAI calcium release-activated calcium modulator 2 | 0.86 | 0.86 | |
| NM_027571 | P2ry12 | purinergic receptor P2Y, G-protein coupled 12 | 0.88 | 0.87 | |
| NM_001042499 | Rabl3 | RAB, member of RAS oncogene family-like 3 | 0.92 | 0.91 | |
| NM_007706 | Socs2 | suppressor of cytokine signaling 2 | 1.32 | 1.30 | |
| NM_133789 | Strn4 | striatin, calmodulin binding protein 4 | 0.93 | 0.92 | |
|
| |||||
| NM_027560 | Arrdc2 | arrestin domain containing 2 | 1.11 | 1.13 | |
| NM_010634 | Fabp5 | fatty acid binding protein 5, epidermal | 0.79 | 0.81 | |
| NM_021272 | Fabp7 | fatty acid binding protein 7, brain | 0.69 | 0.71 | |
| NM_175112 | Rae1 | RAE1 RNA export 1 homolog (S. pombe) | 0.94 | 0.92 | |
| NM_009155 | Sepp1 | selenoprotein P, plasma, 1 | 1.17 | 1.08 | |
| NM_178639 | Sfxn5 | sideroflexin 5 | 0.93 | 0.93 | |
| NM_146198 | Slc5a11 | solute carrier family 5 (sodium/glucose cotransporter), member 11 | 1.14 | 1.21 | |
| NM_138599 | Tomm70a | translocase of outer mitochondrial membrane 70 homolog A (yeast) | 0.90 | 0.88 | |
|
| |||||
| NM_025675 | Atpbd4 | ATP binding domain 4 | 0.86 | 0.91 | |
| BC090976 | BC022687 | cDNA sequence BC022687 | 0.89 | 0.90 | |
| NM_001166164 | Ccdc74a | coiled-coil domain containing 74A | 0.89 | 0.89 | |
| NM_030179 | Clip4 | CAP-GLY domain containing linker protein family, member 4 | 0.91 | 0.88 | |
| NM_153507 | Cpne2 | copine II | 0.91 | 0.92 | |
| NM_146067 | Cpped1 | calcineurin-like phosphoesterase domain containing 1 | 0.86 | 0.88 | |
| NM_026062 | Fam69a | family with sequence similarity 69, member A | 0.87 | 0.87 | |
| NM_001033550 | Lrrc8b | leucine rich repeat containing 8 family, member B | 0.92 | 0.92 | |
| NM_026845 | Ppil1 | peptidylprolyl isomerase (cyclophilin)-like 1 | 0.87 | 0.83 | |
| NM_024196 | Tbc1d20 | TBC1 domain family, member 20 | 0.90 | 0.89 | |
The genes in Table 2 have FDR-adjusted p-values for each individual comparison under 0.25. Expression is given as fold change in lactating maternal LS relative to pups removed or virgin groups.